Related Experiment Video
Updated: Feb 16, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4
1a Department of Orthopaedic , The People's Hospital of Kaizhou District , Chongqing , PR China.
Abstract:
Abnormal expression and dysfunction of microRNAs are correlated with osteosarcoma (OS). This study demonstrated that the miR-187 level in OS tissues and cell lines was decreased. The proliferation and metastatic abilities of U-2OS cells were inhibited by miR-187 overexpression and promoted by miR-187 knockdown. Moreover, miR-187 also inhibited growth and metastasis of OS cells in vivo. Furthermore, we revealed that miR-187 could interact with S100A4 3'-UTR and inhibit S100A4 expression in OS cells. In summary, miR-187 inhibits growth and metastasis of OS cells by downregulating S100A4, which might be a potential biomarker and therapeutic target of OS.
Insights
MicroRNA-187 (miR-187) is downregulated in osteosarcoma (OS). Restoring miR-187 inhibits OS cell growth and metastasis by targeting S100A4, suggesting its potential as a therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) play crucial roles in cellular processes.
- Dysregulated miRNA expression is implicated in various cancers, including osteosarcoma (OS).
- Specific miRNAs may serve as diagnostic biomarkers or therapeutic targets for OS.
Purpose of the Study:
- To investigate the role of miR-187 in osteosarcoma.
- To identify the molecular mechanisms underlying miR-187's function in OS.
- To evaluate miR-187 as a potential therapeutic target for OS.
Main Methods:
- Quantitative real-time PCR to assess miR-187 expression levels in OS tissues and cell lines.
- In vitro experiments involving miR-187 overexpression and knockdown in U-2OS cells to evaluate proliferation and metastasis.
- In vivo studies using mouse models to assess the effect of miR-187 on OS tumor growth and metastasis.
- Luciferase reporter assays to confirm the interaction between miR-187 and the S100A4 3'-UTR.
Main Results:
- miR-187 expression was significantly decreased in OS tissues and cell lines compared to normal controls.
- Overexpression of miR-187 inhibited proliferation and metastasis of OS cells in vitro.
- Knockdown of miR-187 promoted proliferation and metastasis of OS cells in vitro.
- miR-187 suppressed OS cell growth and metastasis in vivo.
- miR-187 directly targets the 3'-UTR of S100A4, leading to its downregulation in OS cells.
Conclusions:
- miR-187 functions as a tumor suppressor in osteosarcoma.
- miR-187 inhibits osteosarcoma growth and metastasis by downregulating S100A4 expression.
- miR-187 holds potential as a diagnostic biomarker and therapeutic target for osteosarcoma.
More Related Videos
04:25Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
07:44Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay
Published on: March 12, 2018
Related Concept Videos
MicroRNAs
MicroRNAs
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Feedback Inhibition
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Enzyme Inhibition